Galmed Pharma (GLMD) Reports Q1 EPS of $0.17

Galmed Pharma (NASDAQ: GLMD) reported Q1 EPS of $0.17, versus $0.17 reported last year.

For earnings history and earnings-related data on Galmed Pharma (GLMD) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• First Hydrogen signs deal to acquire 60% stake in robotics IP firm
• Casey's General Stores (CASY) Tops Q1 EPS by 69c